# Changes in androgen profile over the menstrual cycle and hormonal contraceptive phases in physically active females

**Authors:** Vera M. Salmi, Ritva S. Mikkonen, Ida E. Löfberg, Kelly L. McNulty, Kirsty M. Hicks, Anthony C. Hackney, Johanna K. Ihalainen

PMC · DOI: 10.1186/s12905-025-04253-6 · BMC Women's Health · 2026-01-27

## TL;DR

This study examines how androgen levels change during the menstrual cycle and with hormonal contraceptives in physically active women.

## Contribution

The study provides new insights into androgen fluctuations during the menstrual cycle and hormonal contraceptive use.

## Key findings

- In naturally menstruating women, testosterone and DHEA levels were higher during the ovulatory phase.
- Hormonal contraceptive users showed stable androgen levels across different phases.
- IUD users had fluctuating testosterone levels, peaking at mid-cycle.

## Abstract

Concentrations of female sex hormones fluctuate during the menstrual cycle (MC), while hormonal contraceptives (HC) generally suppress hypothalamic-pituitary-ovarian axis function resulting in lower concentrations of endogenous estradiol (E2) and progesterone (P4). Little attention has been paid to changes in androgen concentrations during MC and HC phases. Therefore, the aim of this study was to investigate changes in androgen concentrations over the MC and HC phases.

The study was a cross-sectional analysis across MC and HC phases using four time points. E2, P4, follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (tT), free testosterone (fT), sex hormone-binding globulin (SHBG), dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) were analyzed from the serum of healthy, physically active, naturally menstruating (NM = 36), hormonal intrauterine device using (IUD = 12) and combined HCs using (CHC = 25) females.

In NM, concentrations of tT (β = 0.16, p = 0.050), fT (β = 1.85, p < 0.001) and DHEA (β = 5.29, p = 0.045) were significantly higher at ovulatory phase and concentrations of DHEA-S at the mid-follicular phase (β = 0.32, p = 0.012) compared to bleeding. In IUD, tT concentrations fluctuated significantly being highest at mid-cycle (β = 0.34, p = 0.001) compared to the sample defined as measurement 1 (based on bleeding and/or hormonal concentrations). In CHC, concentrations of E2, P4, tT, fT, DHEA, and DHEA-S remained unchanged between the HC phases.

Since the endogenous hormonal milieu, including androgens, may affect female physiology, considering the fluctuation in androgen levels over the MC and HC phases may be of importance in physiological research.

The online version contains supplementary material available at 10.1186/s12905-025-04253-6.

## Linked entities

- **Chemicals:** estradiol (PubChem CID 450), progesterone (PubChem CID 5994), testosterone (PubChem CID 6013), dehydroepiandrosterone (PubChem CID 5881), dehydroepiandrosterone sulfate (PubChem CID 12594)

## Full-text entities

- **Genes:** SHBG (sex hormone binding globulin) [NCBI Gene 6462] {aka ABP, SBP, TEBG}
- **Diseases:** CHC (MESH:D019698), bleeding (MESH:D006470), IUD (MESH:D058736)
- **Chemicals:** fT (-), P4 (MESH:C015586), E2 (MESH:D004958), DHEA (MESH:D003687), tT (MESH:D013739), progesterone (MESH:D011374)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12918223/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12918223/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12918223/full.md

---
Source: https://tomesphere.com/paper/PMC12918223